G-CSF+DAC+BUCY vs G-CSF+DAC+BF Conditioning Regimen for Secondary Acute Myeloid Leukemia Undergoing Allo-HSCT

Clinical trial NCT05449899 · UNKNOWN

Trial details

NCT number: NCT05449899
Sponsor: Nanfang Hospital, Southern Medical University
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Secondary Acute Myeloid Leukemia Evolving From MDS Allogeneic Hematopoietic Stem Cell Transplantation Conditioning

Start date: 2022-07-01
Primary completion: 2023-12-01
Enrollment: 232

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.